Get the Stockscreener App
1.38
2.82%
-0.04
After Hours:
1.39
0.01
+0.72%
Opko Health Inc stock is traded at $1.38, with a volume of 1.66M.
It is down -2.82% in the last 24 hours and up +2.22% over the past month.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
See More
Previous Close:
$1.42
Open:
$1.41
24h Volume:
1.66M
Relative Volume:
0.59
Market Cap:
$1.10B
Revenue:
$711.41M
Net Income/Loss:
$-133.73M
P/E Ratio:
-7.2632
EPS:
-0.19
Net Cash Flow:
$-199.99M
1W Performance:
-2.13%
1M Performance:
+2.22%
6M Performance:
-15.34%
1Y Performance:
-13.21%
1-Day Range:
$1.37
$1.41
1-Week Range:
$1.37
$1.43
52-Week Range:
$1.11
$2.035
Opko Health Inc Stock (OPK) Company Profile
Name
Opko Health Inc
Sector
Industry
Phone
305-575-4181
Address
4400 BISCAYNE BLVD., MIAMI, FL
Compare OPK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OPK
Opko Health Inc
|
1.38 | 1.13B | 711.41M | -133.73M | -199.99M | -0.19 |
|
TMO
Thermo Fisher Scientific Inc
|
492.72 | 184.93B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
205.82 | 147.00B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
647.09 | 51.77B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
125.66 | 35.50B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
190.81 | 32.08B | 15.70B | 1.24B | 2.01B | 6.91 |
Opko Health Inc Stock (OPK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-25-25 | Initiated | JP Morgan | Neutral |
| Jun-29-23 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Dec-15-22 | Initiated | H.C. Wainwright | Buy |
| Jan-24-22 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Jun-21-21 | Initiated | Ladenburg Thalmann | Buy |
| Nov-25-19 | Initiated | Piper Jaffray | Overweight |
| Mar-02-18 | Downgrade | JP Morgan | Neutral → Underweight |
| Sep-14-17 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-21-16 | Reiterated | Standpoint Research | Buy |
| Jun-03-16 | Initiated | Standpoint Research | Buy |
| Mar-31-16 | Reiterated | Barrington Research | Outperform |
| Oct-16-15 | Initiated | JP Morgan | Overweight |
| Sep-11-15 | Downgrade | Jefferies | Buy → Hold |
| Mar-03-15 | Downgrade | Oppenheimer | Outperform → Perform |
| May-12-14 | Reiterated | Oppenheimer | Outperform |
| Mar-14-14 | Initiated | Oppenheimer | Outperform |
| Nov-13-13 | Reiterated | Ladenburg Thalmann | Buy |
| May-30-13 | Reiterated | Ladenburg Thalmann | Buy |
| Oct-22-12 | Initiated | Barrington Research | Outperform |
| Dec-01-11 | Reiterated | Ladenburg Thalmann | Buy |
| Jul-14-11 | Initiated | Ladenburg Thalmann | Buy |
View All
Opko Health Inc Stock (OPK) Latest News
What earnings revisions data tells us about OPKO Health Inc.Product Launch & Weekly High Conviction Ideas - Newser
What’s the recovery path for long term holders of OPKO Health IncWeekly Volume Report & Fast Gain Swing Alerts - Newser
Can OPKO Health Inc. stock outperform in a bear marketJuly 2025 Pullbacks & Low Risk Entry Point Guides - خودرو بانک
Sculptor Capital LP Takes Position in OPKO Health, Inc. $OPK - MarketBeat
Nuveen LLC Purchases New Position in OPKO Health, Inc. $OPK - MarketBeat
Can OPKO Health Inc. recover in the next quarterJuly 2025 Movers & High Yield Equity Trading Tips - Newser
Quantbot Technologies LP Makes New Investment in OPKO Health, Inc. $OPK - MarketBeat
What high frequency data says about OPKO Health Inc.Quarterly Profit Review & High Accuracy Swing Entry Alerts - Newser
Is it too late to sell OPKO Health IncQuarterly Investment Review & AI Enhanced Execution Alerts - Newser
Will OPKO Health Inc. outperform the marketTrade Risk Summary & Expert Curated Trade Setup Alerts - Newser
What moving averages say about OPKO Health Inc.2025 Trading Volume Trends & Fast Gain Stock Trading Tips - Newser
Best data tools to analyze OPKO Health Inc. stockWeekly Volume Report & AI Driven Price Predictions - Newser
Can swing trading help recover from OPKO Health Inc. lossesWeekly Trade Analysis & Capital Efficiency Focused Ideas - Newser
Using portfolio simulators with OPKO Health Inc. includedJuly 2025 Volume & Risk Managed Investment Signals - Newser
How to track smart money flows in OPKO Health Inc.Options Play & Free Growth Oriented Trading Recommendations - Newser
What’s the recovery path for long term holders of OPKO Health Inc.Weekly Trade Recap & Free High Return Stock Watch Alerts - Newser
Exit strategy if you’re trapped in OPKO Health Inc.Quarterly Portfolio Report & Safe Capital Growth Tips - Newser
Is it too late to sell OPKO Health Inc.Market Activity Summary & Capital Protection Trade Alerts - Newser
OPKO Health, Inc. (NASDAQ:OPK) Receives $2.75 Average Target Price from Analysts - MarketBeat
What MACD signals say about OPKO Health Inc.July 2025 Fed Impact & Verified Swing Trading Watchlist - Newser
Charles Schwab Investment Management Inc. Trims Stake in OPKO Health, Inc. $OPK - MarketBeat
Applying Wyckoff theory to OPKO Health Inc. stockJuly 2025 Patterns & Smart Swing Trading Techniques - Newser
How high can OPKO Health Inc. stock price go in 20252025 Pullback Review & Accurate Intraday Trading Signals - Newser
OPKO Health Inc. stock prediction for this weekGap Up & Verified Stock Trade Ideas - Newser
Is OPKO Health Inc. stock bottoming out2025 Trade Ideas & Daily Oversold Stock Bounce Ideas - Newser
Historical volatility pattern of OPKO Health Inc. visualized2025 Performance Recap & Comprehensive Market Scan Insights - Newser
How to forecast OPKO Health Inc. trends using time seriesJuly 2025 News Drivers & Safe Entry Trade Signal Reports - Newser
Vanguard Group Inc. Boosts Stock Holdings in OPKO Health, Inc. $OPK - MarketBeat
What earnings revisions data tells us about OPKO Health IncJuly 2025 Pullbacks & Short-Term Swing Trade Alerts - Newser
Does OPKO Health Inc. qualify in momentum factor screeningJuly 2025 Trends & Precise Trade Entry Recommendations - Newser
Opko Health Inc Stock (OPK) Financials Data
Revenue
Net Income
Cash Flow
EPS
Opko Health Inc Stock (OPK) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| FROST PHILLIP MD ET AL | CEO & Chairman |
Apr 10 '25 |
Buy |
1.36 |
125,000 |
169,712 |
214,001,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Apr 08 '25 |
Buy |
1.48 |
125,000 |
184,650 |
213,876,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Apr 01 '25 |
Buy |
1.65 |
100,000 |
164,850 |
213,751,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Mar 28 '25 |
Buy |
1.70 |
150,000 |
254,385 |
213,651,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Mar 17 '25 |
Buy |
1.74 |
200,000 |
347,820 |
213,501,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Feb 28 '25 |
Buy |
1.71 |
67,434 |
115,312 |
213,301,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Jan 28 '25 |
Buy |
1.47 |
47,537 |
70,060 |
213,234,014 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Jan 17 '25 |
Buy |
1.47 |
150,000 |
220,425 |
213,186,477 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Jan 15 '25 |
Buy |
1.48 |
500,000 |
740,850 |
213,036,477 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Dec 13 '24 |
Buy |
1.59 |
125,000 |
199,375 |
212,536,477 |
1.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):